Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results
Alessandro Vinciguerra, Andrea Rampi, Mona‐Rita Yacoub, Moreno Tresoldi, Umberto Tanzini, Mario Bussi, Matteo Trimarchi
Topics & Concepts
DupilumabHypereosinophiliaMedicineOmalizumabAdverse effectInternal medicineEosinophiliaMepolizumabComorbidityAsthmaDermatologyIntensive care medicineImmunologyEosinophilImmunoglobulin EAntibodySinusitis and nasal conditionsEosinophilic Disorders and SyndromesIgG4-Related and Inflammatory Diseases